Literature DB >> 26294301

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

James R Fink1, Mark Muzi2, Melinda Peck2, Kenneth A Krohn2.   

Abstract

Standard MR imaging and CT are routinely used for anatomic diagnosis in brain tumors. Pretherapy planning and posttreatment response assessments rely heavily on gadolinium-enhanced MR imaging. Advanced MR imaging techniques and PET imaging offer physiologic, metabolic, or functional information about tumor biology that goes beyond the diagnostic yield of standard anatomic imaging. With the advent of combined PET/MR imaging scanners, we are entering an era wherein the relationships among different elements of tumor metabolism can be simultaneously explored through multimodality MR imaging and PET imaging. The purpose of this review is to provide a practical and clinically relevant overview of current anatomic and physiologic imaging of brain tumors as a foundation for further investigations, with a primary focus on MR imaging and PET techniques that have demonstrated utility in the current care of brain tumor patients.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  brain tumor; magnetic resonance imaging; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 26294301      PMCID: PMC4592410          DOI: 10.2967/jnumed.113.131516

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  120 in total

1.  Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Authors:  Nobuyuki Kawai; Yukito Maeda; Nobuyuki Kudomi; Keisuke Miyake; Masaki Okada; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.

Authors:  Georg Widhalm; Martin Krssak; Georgi Minchev; Adelheid Wöhrer; Tatjana Traub-Weidinger; Thomas Czech; Susanne Asenbaum; Christine Marosi; Engelbert Knosp; Johannes A Hainfellner; Daniela Prayer; Stefan Wolfsberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-22       Impact factor: 10.154

3.  Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; Z Zhang; W Shi; A I Holodny; A M P Omuro
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

4.  Application of magnetic resonance tractography in the perioperative planning of patients with eloquent region intra-axial brain lesions.

Authors:  Anshul Bagadia; Harshad Purandare; Basant K Misra; Santosh Gupta
Journal:  J Clin Neurosci       Date:  2011-03-02       Impact factor: 1.961

5.  Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

Authors:  W B Pope; A Lai; R Mehta; H J Kim; J Qiao; J R Young; X Xue; J Goldin; M S Brown; P L Nghiemphu; A Tran; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

6.  Diffusion tensor MR imaging of cerebral gliomas: evaluating fractional anisotropy characteristics.

Authors:  M L White; Y Zhang; F Yu; S A Jaffar Kazmi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

Review 7.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

Authors:  M J van den Bent; J S Wefel; D Schiff; M J B Taphoorn; K Jaeckle; L Junck; T Armstrong; A Choucair; A D Waldman; T Gorlia; M Chamberlain; B G Baumert; M A Vogelbaum; D R Macdonald; D A Reardon; P Y Wen; S M Chang; A H Jacobs
Journal:  Lancet Oncol       Date:  2011-04-05       Impact factor: 41.316

8.  Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.

Authors:  Craig J Galbán; Thomas L Chenevert; Charles R Meyer; Christina Tsien; Theodore S Lawrence; Daniel A Hamstra; Larry Junck; Pia C Sundgren; Timothy D Johnson; Stefanie Galbán; Judith S Sebolt-Leopold; Alnawaz Rehemtulla; Brian D Ross
Journal:  Clin Cancer Res       Date:  2011-04-28       Impact factor: 12.531

9.  Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.

Authors:  Tiernan J D Byrnes; Thomas R Barrick; B Anthony Bell; Chris A Clark
Journal:  NMR Biomed       Date:  2011-01       Impact factor: 4.044

10.  Pre-surgical planning and MR-tractography utility in brain tumour resection.

Authors:  A Romano; G D'Andrea; G Minniti; L Mastronardi; L Ferrante; L M Fantozzi; A Bozzao
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

View more
  36 in total

1.  Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Authors:  Giovanni Morana; Arnoldo Piccardo; Domenico Tortora; Matteo Puntoni; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Manlio Cabria; Antonio Verrico; Claudia Milanaccio; Andrea Rossi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 9.236

Review 2.  From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.

Authors:  A Zygogianni; M Protopapa; A Kougioumtzopoulou; F Simopoulou; S Nikoloudi; V Kouloulias
Journal:  Clin Transl Oncol       Date:  2018-01-15       Impact factor: 3.405

3.  Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

Authors:  Arnoldo Piccardo; Domenico Tortora; Samantha Mascelli; Mariasavina Severino; Gianluca Piatelli; Alessandro Consales; Marco Pescetto; Veronica Biassoni; Elisabetta Schiavello; Michela Massollo; Antonio Verrico; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi; Giovanni Morana
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-27       Impact factor: 9.236

4.  Glioma grading by dynamic susceptibility contrast perfusion and 11C-methionine positron emission tomography using different regions of interest.

Authors:  Cornelia Brendle; Johann-Martin Hempel; Jens Schittenhelm; Marco Skardelly; Gerald Reischl; Benjamin Bender; Ulrike Ernemann; Christian la Fougère; Uwe Klose
Journal:  Neuroradiology       Date:  2018-02-20       Impact factor: 2.804

5.  Computer-based radiological longitudinal evaluation of meningiomas following stereotactic radiosurgery.

Authors:  Eli Ben Shimol; Leo Joskowicz; Ruth Eliahou; Yigal Shoshan
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-10-14       Impact factor: 2.924

Review 6.  Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1.

Authors:  Felice D'Arco; Sinead Culleton; Laurens J L De Cocker; Kshitij Mankad; Jorge Davila; Benita Tamrazi
Journal:  Pediatr Radiol       Date:  2018-07-06

7.  Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.

Authors:  L C Bell; M D Does; A M Stokes; L C Baxter; K M Schmainda; A C Dueck; C C Quarles
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-06       Impact factor: 3.825

Review 8.  Neurologic Applications of PET/MR Imaging.

Authors:  Michelle M Miller-Thomas; Tammie L S Benzinger
Journal:  Magn Reson Imaging Clin N Am       Date:  2017-01-26       Impact factor: 2.266

9.  Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [18F]FDG PET.

Authors:  Hongzan Sun; Jun Xin; Jinyuan Zhou; Zaiming Lu; Qiyong Guo
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

10.  Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging.

Authors:  Jennifer A Geisler; Jonathan M Spehar; Sarah A Steck; Anna Bratasz; Reena Shakya; Kimerly Powell; Gina M Sizemore
Journal:  J Vis Exp       Date:  2020-06-07       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.